哈药股份
(600664)
| 流通市值：236.24亿 | | | 总市值：236.24亿 |
| 流通股本：25.19亿 | | | 总股本：25.19亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 8,295,656,520.47 | 4,175,172,325.87 | 15,964,064,818.53 | 12,021,256,198.55 |
| 营业收入 | 8,295,656,520.47 | 4,175,172,325.87 | 15,964,064,818.53 | 12,021,256,198.55 |
| 二、营业总成本 | 7,791,338,229.06 | 3,962,817,877.77 | 15,347,569,067.04 | 11,509,872,116.8 |
| 营业成本 | 6,107,277,440.67 | 3,168,650,355.91 | 11,815,835,067.99 | 8,892,808,851.49 |
| 税金及附加 | 73,227,302.23 | 34,211,132.15 | 118,968,985.23 | 90,722,520.92 |
| 销售费用 | 1,152,244,363.52 | 535,343,757.98 | 2,372,245,450.38 | 1,797,826,889.62 |
| 管理费用 | 376,878,919.45 | 185,813,120.5 | 853,652,771.11 | 606,439,310.7 |
| 研发费用 | 60,401,628.41 | 27,022,399.06 | 145,006,061.92 | 93,697,452.17 |
| 财务费用 | 21,308,574.78 | 11,777,112.17 | 41,860,730.41 | 28,377,091.9 |
| 其中:利息费用 | 18,111,392.21 | 8,008,490.94 | 42,554,725.95 | 31,791,591.33 |
| 其中:利息收入 | 10,303,334.85 | 4,200,379.31 | 24,349,671.19 | 20,915,983.91 |
| 三、其他经营收益 | | | | |
| 加:投资收益 | 16,000 | - | -768,285.37 | 293,032.8 |
| 资产处置收益 | 35,828,207.74 | 254,259.7 | 3,827,706.33 | 4,270,973.73 |
| 资产减值损失(新) | -16,567,349.21 | -245,850.61 | -30,945,084.51 | -16,518,830.11 |
| 信用减值损失(新) | -22,796,441.89 | -16,501,025.26 | -74,733,581.61 | -63,749,889.34 |
| 其他收益 | 20,203,924.61 | 12,275,596 | 72,150,237 | 50,027,178.21 |
| 四、营业利润 | 521,002,632.66 | 208,137,427.93 | 586,026,743.33 | 485,706,547.04 |
| 加:营业外收入 | 1,632,554.9 | 283,678.14 | 1,859,687.4 | 2,304,802.6 |
| 减:营业外支出 | 4,776,717.36 | 1,988,674.51 | 15,147,808.65 | 6,972,263.77 |
| 五、利润总额 | 517,858,470.2 | 206,432,431.56 | 572,738,622.08 | 481,039,085.87 |
| 减:所得税费用 | 108,782,838.29 | 45,360,507.6 | 173,961,109.59 | 139,344,422.73 |
| 六、净利润 | 409,075,631.91 | 161,071,923.96 | 398,777,512.49 | 341,694,663.14 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 409,075,631.91 | 161,071,923.96 | 398,777,512.49 | 341,694,663.14 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 410,320,866.91 | 161,133,176.47 | 361,597,035.74 | 328,594,490.47 |
| 少数股东损益 | -1,245,235 | -61,252.51 | 37,180,476.75 | 13,100,172.67 |
| 扣除非经常损益后的净利润 | 354,972,377.36 | 153,492,866.69 | 307,590,327.43 | 288,864,230.08 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.16 | 0.06 | 0.14 | 0.13 |
| (二)稀释每股收益 | 0.16 | 0.06 | 0.14 | 0.13 |
| 八、其他综合收益 | 516,936.15 | 33,249.11 | -2,503,704.81 | 297,097.02 |
| 归属于母公司股东的其他综合收益 | 516,936.15 | 33,249.11 | -2,503,704.81 | 297,097.02 |
| 九、综合收益总额 | 409,592,568.06 | 161,105,173.07 | 396,273,807.68 | 341,991,760.16 |
| 归属于母公司股东的综合收益总额 | 410,837,803.06 | 161,166,425.58 | 359,093,330.93 | 328,891,587.49 |
| 归属于少数股东的综合收益总额 | -1,245,235 | -61,252.51 | 37,180,476.75 | 13,100,172.67 |
| 公告日期 | 2026-08-26 | 2026-04-23 | 2026-04-23 | 2025-10-25 |
| 审计意见(境内) | | | 标准无保留意见 | |